Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010 (2010), Article ID 708067, 5 pages
http://dx.doi.org/10.1155/2010/708067
Review Article

Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects

1Department of Experimental Medicine, Internal Medicine Unit, Università degli Studi di Roma ‘La Sapienza’, 00161 Rome, Italy
2Department of Clinical Medicine, Clinical Immunology Unit-Scleroderma Center, Università degli Studi di Roma ‘La Sapienza’, 00161 Rome, Italy

Received 10 May 2010; Revised 22 June 2010; Accepted 27 July 2010

Academic Editor: V. D. Steen

Copyright © 2010 Antonio Aversa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Carwile LeRoy, C. Black, R. Fleischmajer et al., “Scleroderma (systemic sclerosis): classification, subsets and pathogenesis,” Journal of Rheumatology, vol. 15, no. 2, pp. 202–205, 1988. View at Google Scholar · View at Scopus
  2. T. A. Medsger Jr., “Systemic sclerosis (scleroderma): clinical aspects,” in Arthritis and Allied Conditions, W. J. Koopman, Ed., pp. 1590–1624, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 14th edition, 2001. View at Google Scholar
  3. M. B. Kahaleh, “Vascular involvement in systemic sclerosis (SSc),” Clinical and Experimental Rheumatology, vol. 22, no. 3, pp. S19–S23, 2004. View at Google Scholar · View at Scopus
  4. M. Hasegawa, Y. Nagai, A. Tamura, and O. Ishikawa, “Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis,” British Journal of Dermatology, vol. 155, no. 6, pp. 1159–1164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. T. Konttinen, Z. Mackiewicz, P. Ruuttila et al., “Vascular damage and lack of angiogenesis in systemic sclerosis skin,” Clinical Rheumatology, vol. 22, no. 3, pp. 196–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Rosato, F. Borghese, S. Pisarri, and F. Salsano, “Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis,” Journal of Rheumatology, vol. 36, no. 10, pp. 2257–2263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Cerinic, G. Valentini, G. G. Sorano et al., “Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis,” Seminars in Arthritis and Rheumatism, vol. 32, no. 5, pp. 285–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kawaguchi, K. Suzuki, M. Hara et al., “Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 53, no. 8, pp. 506–510, 1994. View at Google Scholar · View at Scopus
  9. F. Salsano, C. Letizia, M. Proietti et al., “Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 4, pp. 761–770, 2005. View at Google Scholar · View at Scopus
  10. C. Letizia, C. Danese, and E. D'Erasmo, “Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon,” Journal of Rheumatology, vol. 26, no. 3, pp. 759–760, 1999. View at Google Scholar · View at Scopus
  11. G. N. Andersen, K. Caidahl, E. Kazzam et al., “Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules e-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1,” Arthritis and Rheumatism, vol. 43, no. 5, pp. 1085–1093, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. G. H. Stummvoll, M. Aringer, J. Grisar et al., “Increased transendothelial migration of scleroderma lymphocytes,” Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 569–574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Riccieri, T. Rinaldi, A. Spadaro et al., “Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities,” Clinical Rheumatology, vol. 22, no. 2, pp. 102–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Cerinic, G. Valentini, G. G. Sorano et al., “Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis,” Seminars in Arthritis and Rheumatism, vol. 32, no. 5, pp. 285–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. T. Konttinen, Z. Mackiewicz, P. Ruuttila et al., “Vascular damage and lack of angiogenesis in systemic sclerosis skin,” Clinical Rheumatology, vol. 22, no. 3, pp. 196–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Worda, R. Sgonc, H. Dietrich et al., “In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay,” Arthritis and Rheumatism, vol. 48, no. 9, pp. 2605–2614, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Lawrence, D. Khanna, R. Misra, and A. Aggarwal, “Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis,” Dermatology Online Journal, vol. 12, no. 1, article 2, 2006. View at Google Scholar · View at Scopus
  18. P. Hong, J. E. Pope, J. M. Ouimet, E. Rullan, and J. R. Seibold, “Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis,” Journal of Rheumatology, vol. 31, no. 3, pp. 508–513, 2004. View at Google Scholar · View at Scopus
  19. E. V. Lally and S. A. Jimenez, “Erectile failure in systemic sclerosis,” New England Journal of Medicine, vol. 322, no. 19, pp. 1398–1399, 1990. View at Google Scholar · View at Scopus
  20. A. Aversa, M. Proietti, R. Bruzziches, F. Salsano, and G. Spera, “The penile vasculature in systemic sclerosis: a duplex ultrasound study,” Journal of Sexual Medicine, vol. 3, no. 3, pp. 554–558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. R. Akram, C. E. Handler, M. Williams et al., “Angiographically proven coronary artery disease in scleroderma,” Rheumatology, vol. 45, no. 11, pp. 1395–1398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Merla, G. L. Romani, A. Tangherlini et al., “Penile cutaneous temperature in systemic sclerosis: a thermal imaging study,” International Journal of Immunopathology and Pharmacology, vol. 20, no. 1, pp. 139–144, 2007. View at Google Scholar · View at Scopus
  23. A. Nehra, S. J. Hall, G. Basile et al., “Systemic sclerosis and impotence: a clinicopathological correlation,” Journal of Urology, vol. 153, no. 4, pp. 1140–1146, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Aversa, S. Basciani, P. Visca et al., “Platelet-derived growth factor (PDGF) and PDGF receptors in rat corpus cavernosum: changes in expression after transient in vivo hypoxia,” Journal of Endocrinology, vol. 170, no. 2, pp. 395–402, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Granchi, G. B. Vannelli, L. Vignozzi et al., “Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells,” Molecular Human Reproduction, vol. 8, no. 12, pp. 1053–1064, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Varga and D. Abraham, “Systemic sclerosis: a prototypic multisystem fibrotic disorder,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 557–567, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. T. Delis, A. F. Lennox, A. N. Nicolaides, and J. H. Wolfe, “Sympathetic autoregulation in peripheral vascular disease,” British Journal of Surgery, vol. 88, no. 4, pp. 523–528, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Baubet, M. Brunet, P. Garcia De La Peña-Lefebvre et al., “Psychiatric manifestations of systemic sclerosis,” Annales de Medecine Interne, vol. 153, no. 4, pp. 237–241, 2002. View at Google Scholar · View at Scopus
  29. E. Matsuura, A. Ohta, F. Kanegae et al., “Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma,” Journal of Rheumatology, vol. 30, no. 8, pp. 1782–1787, 2003. View at Google Scholar · View at Scopus
  30. M. Cutolo, A. Sulli, C. Pizzorni, and S. Accardo, “Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis,” Journal of Rheumatology, vol. 27, no. 1, pp. 155–160, 2000. View at Google Scholar · View at Scopus
  31. N. Galiè, H. A. Ghofrani, A. Torbicki et al., “Sildenafil citrate therapy for pulmonary arterial hypertension,” New England Journal of Medicine, vol. 353, no. 20, pp. 2148–2157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. E. D. Michelakis, W. Tymchak, M. Noga et al., “Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension,” Circulation, vol. 108, no. 17, pp. 2066–2069, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. H. A. Ghofrani, R. Wiedemann, F. Rose et al., “Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial,” Lancet, vol. 360, no. 9337, pp. 895–900, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Fries, K. Shariat, H. von Wilmowsky, and M. Böhm, “Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy,” Circulation, vol. 112, no. 19, pp. 2980–2985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Rosenkranz, F. Diet, T. Karasch, J. Weihrauch, K. Wassermann, and E. Erdmann, “Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon,” Annals of Internal Medicine, vol. 139, no. 10, pp. 871–873, 2003. View at Google Scholar · View at Scopus
  36. A. Aversa, M. Caprio, G. M. C. Rosario, and G. Spera, “Endothelial effects of drugs designed to treat erectile dysfunction,” Current Pharmaceutical Design, vol. 14, no. 35, pp. 3768–3778, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Rosato, C. Letizia, M. Proietti et al., “Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis,” Journal of Biological Regulators and Homeostatic Agents, vol. 23, no. 1, pp. 23–29, 2009. View at Google Scholar · View at Scopus
  38. U. A. Walker, A. Tyndall, and R. Ruszat, “Erectile dysfunction in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 68, no. 7, pp. 1083–1085, 2009. View at Publisher · View at Google Scholar · View at Scopus